Physician profile
Alexandre Aalam
NPI 1780658039
$8,195.84
in general payments reported to CMS, 2019-2025
8 companies · $54.12 in 2025
The $54.12 reported for 2025 was less than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,182 · 2020: $5,816 · 2021: $267 · 2022: $415 · 2023: $369 · 2024: $93.29 · 2025: $54.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $6,300.30 | 2019-2023 | Nobelactive |
| Hu-Friedy Mfg. Co., LLC | $833.45 | 2019 | |
| Straumann USA LLC | $792.37 | 2021-2025 | |
| Zimvie INC. | $73.84 | 2024 | |
| Ormco Corporation | $69.31 | 2023 | |
| Zimmer Biomet Holdings, INC. | $43.75 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $43.70 | 2020 | |
| Envista Holdings Corporation | $39.12 | 2025 | Tf Obturators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Aalam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.